1. Introduction {#sec0005}
===============

Phytochemicals found in fruits and vegetables are known to have antioxidant effects against pro-oxidative damage that is induced by environmental chemicals \[[@bib0005]\]. However, their protective effects against chemically-induced tissues damages are dependent on several factors such as dosages, molecular polarities, and experimental designs \[[@bib0010], [@bib0015], [@bib0020]\]. The optimal dosages of some phytochemicals required to provide protective effects against experimentally-induced tissue oxidative damages are often difficult to extrapolate. This is reported to be due to their low intestinal absorption in the biological system \[[@bib0025]\] or that different interstitial concentrations are required for different tissues \[[@bib0015]\]. For instance, gallic acid (GAL) has the capacity to act as pro-oxidant at high doses and produces deleterious effects in tissues \[[@bib0030], [@bib0035], [@bib0040]\] whereas, at low doses it acts as antioxidant and exerts beneficial effects on the health of humans including cardiovascular diseases, chemoprevention of cancers and mitochondrial damage of several tissues \[[@bib0045], [@bib0050], [@bib0055]\]. Furthermore, several studies with many phytochemicals including quercetin (QUE), hesperetin, naringenin, myricetin and morin have established that these flavonoids have both antioxidant and pro-oxidant effects at different doses \[[@bib0060],[@bib0065]\]. The health benefits of GAL and QUE facilitate them to be used as antioxidant ingredients in poly (vinyl alcohol) film formulations for food packaging \[[@bib0070]\].

The tissues of animals are rich in antioxidants and radical scavengers such as glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) which protect them from oxidative stress and lipid peroxidative damage \[[@bib0020]\]. Tissues that are endowed with antioxidant protective agents are less vulnerable to oxidative damage and are said to be in good health status \[[@bib0020]\]. In our previous studies, GAL at 100 mg/kg body weight produces deleterious effects on the testis, kidney and liver \[[@bib0020],[@bib0040]\].

In several *in vivo* studies with rats were GAL exhibits antioxidant effects, the doses used are lower than 100. Similarly, our previous studies with rodent models showed that low dosages of QUE (5−20 mg/kg body weight) produce beneficial effects on the antioxidant defence of several tissues \[[@bib0015]\] and exhibit anticancer and apoptosis-inducing effects *in vitro* and *in vivo* at higher doses \[[@bib0080]\] but not when oxidative stress had already been induced from exogenous sources \[[@bib0015]\]. For example, in atrazine-induced oxidative damage, QUE at 20 mg/kg body weight exacerbated the pro-oxidant effects of atrazine \[[@bib0010]\] whereas doses of QUE as low as 5 mg/kg body weight did not show protective effects in these experimental models \[[@bib0015]\]. The dose of QUE was required to be increased to 10 mg/kg body weight to provide protective effects against oxidative damage in the liver and kidney but not the brain tissue of adult rats \[[@bib0015]\]. Furthermore, doses of QUE higher than was used in the studies above \[[@bib0010],[@bib0015]\] were also observed to have antioxidant protective effects in several tissues of different experimental models \[[@bib0085],[@bib0090]\]. However, the antioxidant protective effects of QUE in tissues and cells at low doses were little in tissues/cells in the absence of exogenous stress \[[@bib0095]\]. Thus there appear to be difficulty in extrapolating a single dose for QUE that provide protective effects in tissues were oxidative stress was induced by environmental chemicals under different experimental settings. To further illustrate this, we studied the effect of QUE at a dose of 50 mg/kg body weight, and then compared its effects with GAL against exogenously-induced oxidative damage. Quercetin metabolites have been found in the plasma of rats administered with this dose of QUE \[[@bib0100]\], and consistent with previous reports, in which QUE was absorbed from the small intestine \[[@bib0105]\].

Phthalate esters are ubiquitously present in several consumer products and are known to induce oxidative stress in experimental models \[[@bib0110],[@bib0115]\]. This effect has been associated with tissue atrophy, impaired tissue antioxidant defence and nephrotoxicity in different experimental models \[[@bib0120], [@bib0125], [@bib0130], [@bib0135], [@bib0140]\]. The role of oxidative stress in butyl phthalate -induced toxicity was fuadministration of antioxidants prevented phthalate ester-induced tissue damage in rats \[[@bib0110]\].

The purpose of this study was to evaluate the protective effects of QUE and GAL against induced oxidative stress *in vivo* in rats?\" kidney and *in vitro* in HEK-293 human embryonic kidney cell lines. At the same dose tested (50 mg/kg) for both compounds, we observed from the *in vivo* data that GAL protected the kidney against DnBP-induced oxidative stress but QUE did not. But data from the *in vitro* study allowed us to suggest that low concentration of QUE (2 μM) protected HEK-293 cells from oxidative stress-induced by H~2~O~2~.

2. Materials and methods {#sec0010}
========================

2.1. Chemicals and reagents {#sec0015}
---------------------------

Gallic acid, quercetin, hydrogen peroxide and butyl-phthalate (purity, \> 98 %) were purchased from Sigma-Aldrich Corp. (St. Louis, MO USA). All other reagents were of analytical grade and were purchased from the British Drug Houses (Poole, Dorset, UK).

2.2. Animal model, experimental design and sample collection {#sec0020}
------------------------------------------------------------

Adult male Wistar rats (180-225 g) were purchased from the animal colony of the Department of Biochemistry, University of Port Harcourt, and kept in well-ventilated plastic cages. They were allowed to acclimatize for one week before the start of the experiment. The animals were maintained in a room under 12-h light: dark cycles and fed with rat\'s pellets and water *ad libitum*. The experimental protocols including the handling of the animals were approved by the Institutional Research Ethics Committee at the University of Port Harcourt and were in adherence with the endorsement of the National Institute of Health Guidelines for Animal Care and Use of Laboratory Animals (National Institute of Health Publication Number, 85-23).

The animals were randomized into six groups of five rats each and were treated as below:

Group I: Control/vehicle treated (corn oil), 2 mL/kg body weight, oral gavage, every other day for 14 days.

Group II: Di*-n-*butyl phthalate, 1 mL/kg body weight, oral gavage, every other day for 14 days

Group III: Gallic acid (GAL), 50 mg/kg body weight, oral gavage, every day for 7 days and every other day for 14 days.

Group IV: Gallic acid (as in group III) + Di-n-butyl phthalate (as in group II)

Group V: Quercetin (QUE), 50 mg/kg body weight, oral gavage, every day for 7 days and every other day for 14 days.

Group VI: Quercetin (as in group V) + Di-n-butyl phthalate (as in group II)

At the end of the study, the animals were starved overnight, weighed and sacrificed by cervical dislocation followed by decapitation. Blood samples were collected in heparin-coated bottles, allowed to stand for 1 h at room temperature and centrifuged at 4000 revolutions per minute for 15 min to obtain plasma. The two kidneys were removed, pat-dried between two sheets of filter paper and weighed. A 10 % homogenate of the right kidney was obtained by homogenizing the tissue in ice-cold 0.1 M Tris-HCl buffer (pH 7.4) followed by centrifugation at 5000*g*, 4 °C for 15 min. The separated tissue supernatant was used to evaluate the oxidative stress markers: malondialdehyde (MDA), reduced glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT). The left kidneys were fixed in 10 % buffered neutral formalin solution for 24 h, dehydrated in graded alcohol series and embedded in paraffin wax according to the routine procedure. The tissues were cut (5 μm-thick sections) with a rotary microtome and stained routinely with haematoxylin and eosin for microscopy.

2.3. Culture of Human embryonic kidney cell line HEK-293 and treatment of cells {#sec0025}
-------------------------------------------------------------------------------

HEK-293 cells were the kind gift from Prof. Aristobolo M. Silva, Laboratories of Molecular Pathogenesis, Department of Morphology, Federal University of Minas Gerais, Belo Horizonte, Brazil. The cells were grown in Dulbecco?\"s modified Eagle?\"s medium supplemented with 100 U/mL penicillin, 100 μg/mL streptomycin (Invitrogen) and 10 % bovine calf serum (Invitrogen) at 37 °C in a humidified incubator with 5% CO~2~. Before the cells were used for the experiment, they were subjected to viability assay using Trypan Blue, and batches showing more than 95 % viability were used for the experiment. Thereafter, the cells were seeded in 6-wells plate (Nunc International, Rochester, USA) at a density of 2 x 10^5^ cells per well, and were allowed to reach 90-100 % confluence in 48-72 h. After pre-treatment of the cells with GAL (25 or 49 μM) or QUE (2-17 μM or 28-165.43 μM) for 1 h followed by treatment with 200 μM H~2~O~2~ \[[@bib0140], [@bib0145], [@bib0150], [@bib0155], [@bib0160], [@bib0165]\] for 2, 6 or 12 h, the cells were scraped from the culture plates, centrifuged at 5000 x g for 10 min and washed with phosphate buffer (pH 7.4). The cell extracts were suspended in 10 mM phosphate buffer (pH 7.4), homogenized for 30 s and then centrifuged at 5000 × g for 10 min at 4 °C to eliminate cellular debris.

2.4. Dose selection of tested compounds for the *in vivo* and *in vitro* study {#sec0030}
------------------------------------------------------------------------------

The dose and route of administration of DnBP were established from earlier published studies \[[@bib0110],[@bib0170]\]. Quercetin metabolites were measured in the plasma of rats \[[@bib0100]\] that were treated with QUE at the same dose that was tested in the present study, and the protective effect of gallic acid against chemically-induced oxidative damage in rat tissues has been reported previously at the same dose that was tested in the present study \[[@bib0075]\]. Many other laboratories have also reported the bioavailability of the tested compounds in rats when administered *via* the oral route \[[@bib0105],[@bib0175], [@bib0180], [@bib0185], [@bib0190], [@bib0195]\]. To select the concentrations of the tested flavonoids for the *in vitro* study, we assumed that if there is equal distribution of the flavonoids throughout the body, and that gastrointestinal (GIT) absorption was 100 %, and the rate of GIT absorption of QUE or GAL was the same as that of the excretion/metabolism of both chemicals, then 50 mg/kg body wt. GAL or QUE administered to rats per day should approximate 50 μg/mL in the kidney tissues. This amount is equivalent to 294 μM of GAL and 165μM of QUE. We therefore selected GAL concentrations as 294, 147, 49 and 25 μM and QUE as 165, 83 and 28 μM. After treatment of cells with GAL (25-294 μM) or QUE (28-165 μM) for 24 h, the viability of the cells were tested by the MTT assay as reported previously \[[@bib0200]\]. All tested concentrations of QUE (28-165 μM) did not affect the viability of cells after 24 h. GAL at the concentrations (49-294 μM) tested were toxic to the cells, and the 49 μM concentration decreased cell viability by about 50 % (data not shown). Therefore the 49 μM GAL concentration and the 25 μM GAL concentration which was not toxic to the cells were used in the further studies.

2.5. Determination of oxidative stress markers {#sec0035}
----------------------------------------------

The concentration of MDA in the kidney homogenates and extracts from the cells were determined as previously described \[[@bib0205]\]. The absorbance of the sample mixture was read at 532 nm, and the MDA level was calculated from a standard curve and expressed in μmol MDA per mL. The concentration of GSH was determined in the kidney homogenate using the colouring reagent, 5,5⬲- dithio-bis (2-nitrobenzoic acid) \[[@bib0210]\]. The absorbance of the samples was read at 412 nm in a spectrophotometer and the GSH concentration was calculated from a standard curve and expressed μg GSH per mL. The enzyme activity of SOD in the tissue homogenate was assayed by the method of Misra and Fridovich \[[@bib0215]\]. This assay was based on the inhibition of epinephrine (0.01 %) autoxidation at pH 10.2. One unit of SOD activity was described as the amount of SOD required to cause 50 % inhibition of the oxidation of adrenaline to adrenochrome per min. The absorbance was read at 480 nm in a spectrophotometer against blank containing all the components except the sample. The activity of CAT was estimated in the tissue homogenates and cell extracts as previously reported \[[@bib0220]\]. The specific activity of CAT was calculated using the molar extinction coefficient of H~2~O~2~ at 240 nm, 43.59 L/mol cm. One unit of catalase activity is the amount of protein that converts 1 mmol H~2~O~2~ per min. The protein concentration in the tissue samples was determined by the method of Lowry using bovine serum albumin as the standard \[[@bib0225]\].

2.6. Determination of renal function markers {#sec0040}
--------------------------------------------

The separated plasma samples were processed for the determination of urea, creatinine (CREA) and uric acid using Randox commercial kits (RANDOX Laboratories Ltd., Crumlin, United Kingdom) with an autoanalyzer (LabTech, RE 1201007) and following the manufacturer?\"s protocols.

2.7. Statistical analysis {#sec0045}
-------------------------

Statistical analysis was performed using ANOVA and Tukey?\"s post Hoc Test. Student?\"s *t*-test was done when only two pairs of data were analysed. Data were expressed as mean ± SD, and *p* values less than 0.05 were considered to indicate statistical significance. All data were analysed with GraphPad Prism 6 (GraphPad Software, Inc., San Diego, CA, USA).

3. Results {#sec0050}
==========

3.1. Effects of QUE and GAL on body and kidney weights {#sec0055}
------------------------------------------------------

Animals were observed daily during the experiment, and were in good health till the end of study. To further determine the toxic effects that are associated with the various treatments, the body and kidney weights of the animals were measured. There were no significant changes in body weight between the treated and control groups at 14 days exposure period (Data not shown). Additionally, there were no statistically significant changes (p \> 0.05) in the average kidney weights of the animals at the end of the study (Data not shown).

3.2. Effects of QUE and GAL on DnBP-induced oxidative stress in the kidney {#sec0060}
--------------------------------------------------------------------------

After 14 days of treatments with the tested chemicals, there were no significant changes found in GSH concentrations in the kidney of the QUE, DnBP and DnBP + QUE groups. The level of GSH in the kidney was significantly increased in the GAL and GAL + DnBP groups when compared with the control \[[Fig. 1](#fig0005){ref-type="fig"}A\]. The level of MDA was significantly higher in the kidney of DnBP, QUE and QUE + DnBP groups when compared with the control. There were no significant changes in MDA concentrations in the kidneys of GAL animals when compared with the control group. The concentration of MDA in the kidney homogenates were significantly (p \< 0.05) decreased in the GAL + DnBP group compared to DnBP treated animals \[[Fig. 1](#fig0005){ref-type="fig"}B\]. The activity of SOD was significantly decreased in the kidney of rats treated with DnBP compared to the control group. There were no significant differences found on SOD activities in the kidney after GAL or QUE treatment. The activity of SOD was significantly higher in the GAL + DnBP group compared to the DnBP treated animals. In the QUE + DnBP treated animals, SOD activity was significantly increased when compared to the DnBP treated animals \[[Fig. 1](#fig0005){ref-type="fig"}C\]. The activity of CAT was significantly higher in the kidney of DnBP-treated animals when compared with the control. The kidney homogenates of GAL or QUE treated animals also showed higher activity of CAT when compared with the animals in the control group. In the GAL + DnBP-treated animals, CAT activities were significantly lower when compared to the values obtained from the DnBP treated animals. There was no significant difference found in CAT activity in the kidneys of QUE + DnBP-treated animals compared to the DnBP treated animals \[[Fig. 1](#fig0005){ref-type="fig"}D\].Fig. 1Effects of quercetin (QUE) and gallic acid (GAL) on the level of (A) glutathione (GSH), (B) malondialdehyde (MDA), (C) superoxide dismutase (SOD), and (D) catalase (CAT) in the kidney, of rats after 14-days of oral treatment with di-n-butyl phthalate (DnBP). Values are mean ± SD; n = 5, \*p \< 0.05 *versus* control; \*\*p \< 0.05 *versus* DnBP.Fig. 1

3.3. Effects of QUE and GAL on H~2~O~2~-induced oxidative stress in HEK-293 cells {#sec0065}
---------------------------------------------------------------------------------

HEK-293 cells stimulated with H~2~O~2~ for 2 h led to an increase in CAT activity but did not change MDA level compared to the control \[[Fig. 2](#fig0010){ref-type="fig"}\]. GAL (25 μM) treated cells did not show any change in MDA level, but CAT activity was increased in these cells. In the combined treatment groups, GAL (25 μM) prevented H~2~O~2-~induced increase in CAT activity. Treatment with QUE was observed to increase CAT activity up to the 331 μM concentration followed by a decrease onwards in a dose-dependent manner (415-1 mM). The increased CAT activity that was induced by H~2~O~2~ was decreased on co-treatment with QUE in a dose-dependent manner. As expected, QUE (165.43 μM) treatment alone or in combination with H~2~O~2~ did not change MDA values when compared to the control. Higher concentrations of QUE (331 μM - 1 mM) were found to increase MDA level in a dose-dependent manner when compared to control values, and these effects were synergistic on co-treatment with H~2~O~2~ \[[Fig. 2](#fig0010){ref-type="fig"}\]. After 6 h of treatment, HEK-293 cells stimulated with H~2~O~2~ showed an increase in both CAT activity and MDA level which were decreased on co-treatment with GAL (25 μM). Cells treated with GAL (25 μM) alone did not change MDA level but increased CAT activity when compared with the control \[[Fig. 3](#fig0015){ref-type="fig"}\]. Treatment of cells with lower concentrations of QUE (2-17 μM) did not alter MDA level and CAT activity when compared to the control but prevented H~2~O~2~-induced increased in CAT activity and MDA level \[[Fig. 3](#fig0015){ref-type="fig"}\]. After treatment of HEK-293 cells with H~2~O~2~ for 12 h, CAT activity was decreased and MDA concentration was increased \[[Fig. 4](#fig0020){ref-type="fig"}\]. Treatment of cells with GAL (49 μM) decreased CAT activity and increased MDA concentration. The decrease in CAT activity along with increase in MDA concentration were synergistic in the GAL 49 μM + H~2~O~2~ treated cells \[[Fig. 4](#fig0020){ref-type="fig"}\]. Treatment of HEK-293 cells with QUE (28-165.43 μM) dose-dependently increased CAT activity, and have no effect on the concentration of MDA. In the combined treatment groups, QUE prevented H~2~O~2~-induced decrease in CAT activity and increase in MDA level in a dose-dependent fashion.Fig. 2Effects of high concentrations of quercetin (QUE, 165.43 μM -- 1 mM) in comparison with gallic acid (GAL, 25 μM) alone or in combination with hydrogen peroxide (H~2~O~2~) (200 μM) on (A) malondialdehyde (MDA) level and (B) catalase (CAT) in HEK-293 cells after 2 h. Experiment were performed three times and analysed in triplicates. The data were calculated by taking the mean of three independent experiments and at least three replicates were used in each experiment. \*p \< 0.05 *versus* control; \*\*p \< 0.05 *versus* hydrogen peroxide (H~2~O~2~).Fig. 2Fig. 3Effect of low concentrations of quercetin (QUE, 2-17 μM) in comparison with gallic acid (GAL, 25 μM) alone and in combination with hydrogen peroxide (H~2~O~2~) (200 μM) on (A) malondialdehyde (MDA) level and (B) catalase (CAT) in HEK-293 (human embryonic kidney-293) cells after 6 h. The data were calculated by taking the mean of three independent experiments and at least three replicates were used in each experiment. \*p \< 0.05 *versus* control; \*\*p \< 0.05 *versus* hydrogen peroxide (H~2~O~2~).Fig. 3Fig. 4Effects of different concentrations of quercetin (QUE, 28-165.43 μM) in comparison with gallic acid (GAL, 49 μM) against hydrogen peroxide (H~2~O~2~)-induced changes in (A) malondialdehyde (MDA) level and (B) catalase (CAT) activity in HEK-293 (human embryonic kidney-293) cells after 12 h. The data were calculated by taking the mean of three independent experiments and at least three replicates were used in each experiment. Bars with different letters are different from each other.Fig. 4

3.4. Effect of QUE and GAL on DnBP-induced changes in the plasma profiles of renal function markers {#sec0070}
---------------------------------------------------------------------------------------------------

The plasma levels of uric acid, urea, and CREA were significantly higher in the DnBP-, QUE- and QUE + DnBP-treated rats when compared to the control values. There were no significant differences found in the levels of these renal markers when the values of the GAL-treated animals were compared to the control group. The plasma concentration of uric acid, urea, and CREA were significantly decreased in the GAL + DnBP treated animals when compared to the DnBP group \[[Fig. 5](#fig0025){ref-type="fig"}\].Fig. 5Effects of quercetin (QUE) and gallic acid (GAL) on the plasma indices of renal functions of rats after 14-days of oral treatment with di-n-butyl phthalate (DnBP). Values are mean ± SD; n = 5, \*p \< 0.05 *versus* control; \*\*p \< 0.05 *versus* DnBP. CREA = creatinine.Fig. 5

3.5. Effect of QUE and GAL on DnBP-induced histopathology of the kidney of rats {#sec0075}
-------------------------------------------------------------------------------

Histological examination of the kidney of the control and GAL groups appears normal with no visible lesion. In the kidney of the DnBP- treated animals, many of the tubules are degenerate and have protein casts in the lumina, and showed diffuse glomerular necrosis similar to the kidney of the QUE + DnBP treated animals. The kidney sections of the DnBP + GAL treated animals contain mild to moderate glomerular and tubular degeneration and necrosis. Histologic sections of the kidney of QUE treated animals also showed diffuse severe glomerular and tubular degeneration \[[Fig. 6](#fig0030){ref-type="fig"}\].Fig. 6Cross sections of the kidney of animals at the end of study. Control (A): No visible lesion seen; DnBP treated rats (B and C): many tubules are degenerate and contain protein casts in the lumina (B) and have diffuse severe glomerular and tubular degeneration and necrosis (C); GAL treated rats (D): No visible lesion seen; DnBP + GAL treated rats (E): mild to moderate glomerular and tubular degeneration and necrosis; QUE treated rats (F): diffuse severe glomerular and tubular degeneration; DnBP + QUE-treated rats (G): many tubules are degenerate and contain protein casts in the lumina. Mag ×400, H & E. di-n-butyl phthalate = DnBP; quercetin = QUE; gallic acid = GAL.Fig. 6

4. Discussion {#sec0080}
=============

There are several factors that interfere with the beneficial effects of phytochemicals in experimental animal models including their poor intestinal absorption and distribution in the tissues of biological system, experimental designs and dosages \[[@bib0015],[@bib0230]\]. We reported previously that QUE at 5 mg/kg body weight fails to block experimentally-induced oxidative stress in the kidney of adult rats \[[@bib0015]\]. In the present study, we use a higher dose of QUE (50 mg/kg body weight) that was previously reported to be absorbed in rats after oral administration \[[@bib0185],[@bib0190]\], and compared the effects with the same dose of GAL against DnBP-induced oxidative damage in the kidney of rats. We used this dose expecting to achieve antioxidant effects of both compounds under the same experimental condition. Surprisingly, we observed that GAL was protective but QUE was not protective against oxidative damage *in vivo* in the kidney.

The pro-oxidant effect of QUE in the present study was confirmed by the increased CAT activity MDA concentration in the kidney homogenates of the treated animals. Consequently, the increased CAT activity was insufficient to cope with the high level of the peroxide formed, thereby allowing oxidative stress to be induced. Previous reports from several laboratories have also confirmed that QUE can cause lipid peroxidation \[[@bib0235],[@bib0240]\], and that the tissue MDA content is a function of the concentration of QUE \[[@bib0240]\]. Other laboratories have also reported that DnBP-induced oxidative damage was associated with changes in the antioxidant activities of several tissues \[[@bib0245], [@bib0250], [@bib0255], [@bib0260]\], thereby supporting our results. Because of the observed pro-oxidant effects of QUE, it was expected that the levels of the renal function markers (uric acid, urea and CREA) in the QUE + DnBP-treated animals be at least similar to the values of the DnBP-treated animals, and support the fact that QUE at the tested dose was toxic and did not protect the kidney against DnBP-induced kidney damage. In contrast, GAL co-treatment normalized renal function and prevented DnBP-induced oxidative damage, and was therefore beneficial than QUE in attenuating DnBP-induced oxidative damage. The antioxidant efficacy of GAL against different chemical toxicants induced oxidative stress has been well established in several experimental models. For instance, in rat liver mitochondria *ex vivo* model, GAL prevented bisphenol-induced oxidative damage by inhibiting lipid peroxidation and increasing the content of GSH \[[@bib0265]\]. The antioxidant neuro-protective effects of GAL against induced neuropathic pain were also reported in mice \[[@bib0270]\], thereby supporting our present data on the antioxidant protective effect of GAL in rat kidney stimulated with DnBP. Additionally, the increased GSH concentration in the kidney of GAL-treated animals allowed for the tolerance of reactive oxygen species, thereby making the tissues potentially resistance to oxidative insult \[[@bib0275]\]. This could elucidate the mechanisms by which GAL inhibits chemically-induced oxidative tissue injury.

To further evaluate the antioxidant effects of QUE and GAL against oxidative damage, we stimulated HEK-293 cells with H~2~O~2~ and measured MDA level and CAT activity, and then compared the effects of QUE with that of GAL. In many *in vitro* studies, H~2~O~2~ has been the chemical of choice to induce oxidative stress, and was therefore used to stimulate oxidant damage in HEK-293 cells as reported previously \[[@bib0185], [@bib0190], [@bib0195], [@bib0200], [@bib0205]\]. At the different concentrations of QUE (2--165 μM) tested, QUE reduced H~2~O~2~-induced MDA level and CAT activity suggesting a potent antioxidant activity of QUE at these physiological concentrations *in vitro*. Higher concentrations of QUE (331 μM - 1 mM) were found to have pro-oxidant effects and exerted higher effects on MDA level and CAT on co-treatment with H~2~O~2~. The concentration of GAL was required to be reduced to 25 μM to block the oxidative stress induced by H~2~O~2~. The antioxidant-pro-oxidant effects of GAL have been reported previously to be tightly controlled by their concentrations \[[@bib0020],[@bib0035]\]. Because we assumed that the 50 mg/kg doses for both GAL and QUE administered *in vivo* could be distributed to the kidney tissues to at least 50 μg/mL, a dose of which the equivalent for GAL is 294 μM that was toxic to HEK-293 cells, and the 165 μM equivalent for QUE that exhibited potent antioxidant effect, allowed us to conclude that QUE was more efficient as an antioxidant than GAL *in vitro* but not *in vivo.* Furthermore, the antioxidant effect of QUE against H~2~O~2~-induced oxidative damage was also observed when QUE concentration was reduced to 2 μM, suggesting a wider concentration margin *in vitro* for QUE antioxidant effect compared to GAL. Previously, low concentration of QUE (5 μM) was reported to block oxidative damage in HEK-293 cells \[[@bib0280]\], and even potent antioxidant effects of QUE have been observed previously at 2 μM \[[@bib0240]\]. Furthermore, QUE (0.65 μmol/l) found in the human plasma after dietary intake of an onion rich meal was reported to be a potent antioxidant with the capacity to inhibit lipid peroxidation \[[@bib0285],[@bib0290]\]. Therefore lower concentrations of QUE have potent antioxidant protective effects in HEK-293 cells, and the capacity of QUE to modulate exogenously-induced oxidative stress is due to the concentration achieved in target tissues *in vivo*. Thus, the oxidative damage in the kidney that was observed in the QUE treated animals in the present study suggested a switch from the classical antioxidant properties of QUE observed previously at 20 mg/kg body weight \[[@bib0295]\] to the pro-oxidant effect observed in the present study at 50 mg/kg body weight. However, this dose of QUE that failed to protect against phthalate ester-induced oxidative stress in the kidney were found, and even at higher doses, to exert antioxidant protective effects in oxidative stress models induced by other chemical agents *e.g.* aflatoxin \[[@bib0085]\] and imidacloprid \[[@bib0090]\]. In the study by Hassan et al. \[[@bib0090]\] were the nephro-protective effect of QUE was reported at a dose higher than was used in the present study, QUE was administered before the animals were challenged with the chemical toxicant for 21 days, whereas in the present study, QUE was administered daily for 7 days after which both tested chemicals were administered concurrently for 14 days. The co-treatment of the tested chemicals for a shorter duration and the less number of times the animals were co-treated with QUE might have influence our present results. Another possibility of the disparity in our results with these studies \[[@bib0085],[@bib0090]\] could be that the interaction between butyl phthalate and QUE might have generated toxic metabolites *in vivo* that have potent pro-oxidant properties in the kidney \[[@bib0015],[@bib0235]\]. Hence, the optimal dosages of QUE required to provide antioxidant protective effects in chemically-induced tissue oxidative damages are complex to extrapolate and cannot be generalised.

Overall, it appears that the physiological concentration required for QUE to exhibit antioxidant effect in the kidney is small. Therefore, the 50 mg/kg body weight of QUE administered orally to adult rats in the present study could have been distributed at a high amount in the target tissue. To support these claims, de Boer et al. \[[@bib0300]\] reported that QUE and its metabolites were increased in the kidney of rats after a long term dietary intake, and identified the kidney as one of the possible target tissues for QUE actions. In conclusion, GAL exhibits more versatility than QUE in protecting the kidney against oxidative damage *in vivo* whereas QUE has a wide concentration margin *in vitro* at which it exerts potent antioxidant effects. This new information is important in studies that aim to clarify the effective doses of QUE in clinical and non-clinical toxicology research.
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